Wird geladen...
LDL Cholesterol, Statins And PCSK 9 Inhibitors
Reduction of low density lipoprotein cholesterol (LDLc) is of vital importance for the prevention of atherosclerotic cardiovascular disease (ASCVD). Statin is the most effective therapy today to lower LDLc by inhibiting HMG-CoA-reductase. However despite intensive statin therapy, there remains a res...
Gespeichert in:
| Veröffentlicht in: | Indian Heart J |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593843/ https://ncbi.nlm.nih.gov/pubmed/26432726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.05.020 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|